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Macrophages (Mf) are a heterogeneous population of tissue-resident professional 
phagocytes and a major component of the leukocyte infiltrate at sites of inflammation, 
infection, and tumor growth. They can undergo diverse forms of activation in response to 
environmental factors, polarizing into specialized functional subsets. A common hallmark 
of the pathologic environment is represented by hypoxia. The impact of hypoxia on 
human Mf polarization has not been fully established. The objective of this study was to 
elucidate the effects of a hypoxic environment reflecting that occurring in vivo in diseased 
tissues on the ability of human Mf to polarize into classically activated (proinflammatory 
M1) and alternatively activated (anti-inflammatory M2) subsets. We present data show-
ing that hypoxia hinders Mf polarization toward the M1 phenotype by decreasing the 
expression of T cell costimulatory molecules and chemokine homing receptors and the 
production of proinflammatory, Th1-priming cytokines typical of classical activation, while 
promoting their acquisition of phenotypic and secretory features of alternative activation. 
Furthermore, we identify the triggering receptor expressed on myeloid cells (TREM)-1, a 
member of the Ig-like immunoregulatory receptor family, as a hypoxia-inducible gene in 
Mf and demonstrate that its engagement by an agonist Ab reverses the M2-polarizing 
effect of hypoxia imparting a M1-skewed phenotype to Mf. Finally, we provide evidence 
that Mf infiltrating the inflamed hypoxic joints of children affected by oligoarticular juvenile 
idiopatic arthritis express high surface levels of TREM-1 associated with predominant 
M1 polarization and suggest the potential of this molecule in driving M1 proinflammatory 
reprogramming in the hypoxic synovial environment.
Keywords: macrophages, hypoxia, polarization, immunoregulatory receptors, inflammation
Abbreviations: Mf, macrophages; Mn, monocytes; PAMPs/DAMPs, pathogen- or damage-associated molecular patterns; pO2, 
partial oxygen pressure; TREM-1, triggering receptor expressed on myeloid cells 1; OJIA, oligoarticular juvenile idiopatic 
arthritis; SF, synovial fluid; HMGB1, high-mobility group box 1; SFMCs, SF mononuclear cells; sTREM-1, soluble TREM-1; 
OPN, osteopontin; MFI, mean fluorescence intensity; iDCs, immature DCs.
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inTrODUcTiOn
Macrophages (Mf) are a heterogeneous population of tissue-
resident professional phagocytes and antigen-presenting cells and 
represent a major component of the leukocyte infiltrate at sites of 
inflammation, infection, tissue damage, and tumor growth, origi-
nating from the terminal differentiation of circulating monocytes 
(Mn) (1, 2). They are central effector cells in host defense to 
pathogens and play key roles in the orchestration of both innate 
and adaptive immune responses and the regulation of tissue 
remodeling and repair (3, 4). However, they are also critically 
involved in the pathogenesis of several chronic inflammatory, 
autoimmune, and parasitic diseases and in tumor progression 
(4, 5). Mf are highly versatile cells, able to display distinct pheno-
types and functional programs in different tissues (1, 3, 6). Such 
heterogeneity depends on their ability to undergo different forms 
of activation in response to distinct signals, including cytokines, 
damage- and pathogen-associated molecular patterns (DAMPs/
PAMPs), and metabolites (6–8). The nature of the activating 
stimulus and the combination of different stimuli can profoundly 
impact upon the type of response that occurs, polarizing Mf into 
specialized functional subsets (3, 6, 9).
Two main subsets of polarized Mf have been defined based 
on the type of in vitro stimulation, surface molecule expression 
pattern, secretory profile, and functional properties, which 
mirror the Th1/Th2 dichotomy and represent the extremes of 
a continuum of activation states: the classically activated (type 
1 proinflammatory or M1) and the alternatively activated (type 
2 anti-inflammatory or M2) Mf (1, 8–14). M1-polarized Mf 
originate in response to stimulation with microbial factors, like 
LPS, and Th1 proinflammatory cytokines, such as IFNγ, TNFα, 
and IL-1β, or a combination of the two (10, 15), whereas the M2 
subset comprises various forms of non-classically activated Mf 
originating from exposure to different stimuli, such as the Th2 
cytokines, IL-4, or IL-13 (M2a) (9, 10), immune complexes in 
combination with IL-1β or LPS (M2b) (10, 16), the anti-inflam-
matory cytokines, IL-10 and TGFβ, or glucocorticoids (M2c) 
(8, 17), IL-6, LIF, and MCF (M2d) (18). M1 cells display effector, 
proinflammatory, and Th1-oriented immunostimulatory proper-
ties, representing an important source of reactive oxygen and 
nitrogen intermediates and of proinflammatory Th-1-priming 
cytokines, mediate antimicrobial defense, tissue destruction, and 
antitumor resistance (3, 17). Conversely, M2 cells are oriented 
to Th2-type immunoregulation and resolution of inflammation, 
exhibit tissue remodeling and repair functions, promote wound 
healing, angiogenesis, resistance to parasites, and tumor growth 
through the production of anti-inflammatory cytokines, ECM 
components, remodeling and proangiogenic factors (1, 8–10, 
19). Mf have a remarkable degree of functional plasticity, as 
exemplified by their ability to rapidly and reversibly shift between 
different activation states in vitro in response to changes in the 
activating stimulus, overriding the initial M1/M2-polarization 
(6, 9, 10, 13, 15, 20, 21). Imbalance of M1/M2 polarization or 
repolarization of resident Mf is often associated with various 
diseases, and mixed M1/M2 phenotypes have been described in 
many pathological situations, such as cancer, inflammatory and 
autoimmune disorders, and chronic infections (8, 9, 22, 23).
The factors regulating Mf polarization are the focus of 
intense investigation. A large body of evidence indicates that Mf 
polarization state is not only determined by the type of activat-
ing stimulus but also depends on the local tissue environment 
in which they differentiate (24, 25). A common hallmark of the 
pathologic microenvironment is represented by hypoxia, a condi-
tion of low partial oxygen pressure (pO2, 0–20 mm Hg, hypoxia) 
which arises as a result of disorganized or dysfunctional vascular 
network and diminished O2 supply (5, 26–29). Mf develop ment 
from Mn precursors recruited to tumors and injured/inflamed 
tissues occurs in the setting of low pO2, and adaptation to the 
local hypoxic environment is critical for Mf to fulfill their func-
tions at these sites [reviewed in Ref. (5, 7, 24, 26, 30)]. The role 
of hypoxia in Mf polarization is only beginning to emerge (30), 
and most information have been obtained from studies in rodent 
tumor models (31–33). Relevant interspecies variability has 
been highlighted with regard to the expression of Mf polariza-
tion markers and activation programs, cautioning against direct 
mouse-to-human extrapolation (19, 34–37). Understanding how 
the hypoxic environment affects human Mf polarization may 
have important implications for Mf therapeutic reprogramming 
in chronic inflammatory diseases and tumors.
In this study, we investigated the impact of a hypoxic envi-
ronment reflecting that occurring in diseased tissues on the 
polarization of human Mn-derived Mf. We present data showing 
that development under hypoxic conditions (1% O2) skews Mf 
polarization toward a M2 phenotype and characterize a previ-
ously unrecognized role for the triggering receptor expressed 
on myeloid cells (TREM)-1, a member of the Ig superfamily 
of immunoregulatory receptors (38, 39) that we have recently 
identified as a new hypoxia-inducible gene in Mn-derived DCs 
(40–42), as a critical determinant of hypoxic M2-to-M1 repro-
gramming. Molecules associated with M1 polarization are being 
actively sought as potential diagnostic tools and therapeutic 
targets in chronic inflammatory conditions, including oligoar-
ticular juvenile idiopatic arthritis (OJIA), the most common 
pediatric chronic rheumatic disease characterized by extensive 
and persistent synovial Mn cell infiltration and hypoxia (5, 43). 
We provide evidence that Mf enriched in the synovial fluid 
(SF) from active joints of OJIA patients exhibit high TREM-1 
expression associated with predominant polarization toward the 
M1 phenotype and that OJIA-SFs exert M1 repolarizing effects 
on in  vitro-generated hypoxic M2 cells partially attenuated by 
TREM-1 blocking with the specific synthetic peptide inhibitor, 
LP17 (44). Furthermore, we demonstrate the presence in OJIA-SF 
of high levels of the DAMP molecule, high-mobility group box 1 
(HMGB1), a nuclear DNA-binding protein recently reported to 
be a potential natural ligand of TREM-1 (45, 46).
MaTerials anD MeThODs
Mf Differentiation, Polarization,  
and culture
Peripheral blood mononuclear cells were isolated by density 
gradient centrifugation over a Ficoll cushion (Histopaque 
1077; Sigma-Aldrich, Milano, Italy) from platelet apheresis of 
TaBle 1 | Clinical and laboratory features of OJIA patients at the time of sampling.a
Disease subtype age at sampling 
(years)
Disease duration 
(years)
Female/male esr (mm/h) crP (mg/dl) rF+ (%) ana Previous  
treatment
Persistent  
oligoarticular (n = 3)
11.9b (9.8–14) 4.7 (1.9–8.1) 3/0 18 (1–40) 0.7 (0.46–1.2) 0 −(1 patient) + (2 patients) Nil (3 patients)
Extended  
oligoarticular (n = 3)
15.2 (8.7–20.8) 12. 4 (4.5–18) 2/1 53 (17–88) 1.8 (0.46–2.5) 0 +(3 patients) MTX(2 patients) 
MTX + Etanercept  
(1 patient)
aDisease activity was defined by the presence of joint swelling or limitation of movement with either pain on movement or tenderness.
bResults are expressed as means (ranges in parentheses).
ESR, erithrocyte sedimentation rate; CRP, C-reactive protein; RF, rheumatoid factor antibody; ANA, antinuclear antibody; MTX, methotrexate; Nil, no treatment.
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healthy volunteers (both male and female in a similar propor-
tion) obtained by the Blood Transfusion Center of the Gaslini 
Institute in Genova, Italy, according to a protocol approved 
by the Gaslini’s Ethics Committee and in adherence with the 
Declaration of Helsinki. Written informed consent was obtained 
from all subjects enrolled in the study. Mn were purified by 
MACS immunomagnetic positive selection using the human 
CD14-microbeads isolation kit (Miltenyi Biotec, Bologna, Italy), 
resulting in preparations with a purity of ≥95%, as determined by 
flow cytometry upon staining with anti-CD14 mAb. To generate 
Mf (hereafter referred as M0), primary Mn were cultured for 
6 days in six-well culture plates (BD Falcon, Milano, Italy) with 
RPMI 1640 (Euroclone, Milano, Italy) supplemented with 10% 
heat-inactivated FCS (HyClone, Thermo Scientific, Milano, Italy) 
in the presence of 100 ng/mL of the maturation factor, hM-CSF 
premium grade (Miltenyi Biotec), under normoxic (20% O2) or 
hypoxic (1% O2,) conditions at a concentration of 8 × 105 cells/mL. 
Half medium was replaced at day 3 of culture. Mf differentiation 
was confirmed by positivity for the pan-Mf marker CD68 (47), 
which ranged between 97 and 100% among different donors. Mf 
polarization was obtained by removing conditioned medium 
(CM) and then culturing M0 Mf for additional 24 h with fresh 
medium supplemented with 5% FCS and containing 100 ng/mL 
Ultra-Pure LPS from Escherichia coli O111:B4 (Sigma-Aldrich) 
(for M1 polarization) or 20 ng/mL hIL-4 (Miltenyi Biotec) (for M2 
polarization), as previously described (48, 49), under normoxic or 
hypoxic conditions. M0 Mf cultured with fresh medium without 
polarization factors were used as baseline control. Polarization 
was confirmed by morphological features, assessed under a 
phase-contrast microscope (Olympus CKX41 equipped with an 
Ultra20 Olympus Photocamera for image capturing, Olympus 
Italia Srl, Milano, Italy): M1 cells appeared as adherent cells with a 
classical fried egg morphology, whereas M2 cells as adherent and 
stretched, “spindle-like” cells. Hypoxic conditions were obtained 
by cell incubation and handling in a sealed anaerobic workstation 
incubator (Ruskinn, INVIVO2 400, CARLI Biotec, Roma, Italy), 
incorporating a gas mixing system (Ruskinn Gas Mixer Q) and 
flushed with a mixture of 1% O2, 5% CO2, and 94% N2. Medium 
was allowed to equilibrate in the hypoxic incubator for at least 2 h 
before use. Mf from different donors were polarized in independ-
ent experiments. In some experiments, hypoxic M2-polarized Mf 
were cultured in twelve-well flat-bottom culture plates (Corning 
Life Sciences, Milano, Italy) and incubated for 24 h with SF from 
OJIA patients (see below) diluted 1:2 with fresh medium in 
the presence or absence of 100 ng/mL of the TREM-1-specific 
17-mer peptide, LP17, or a scrambled control peptide (Pepscan, 
Lelystad, The Netherlands), chemically synthesized as described 
by Gibot et al. (44).
sF and sF Mononuclear cell (sFMc) 
isolation
Synovial fluid samples were obtained at the time of therapeutic 
knee arthrocentesis from six children affected by active OJIA 
with synovial effusion, according to the International League of 
Associations for Rheumatology criteria (43) and collected into 
sodium-heparin tubes under vacuum. pO2 levels in SF samples 
were monitored to confirm hypoxic conditions, and specimens 
were handled in the anaerobic incubator to prevent cell reoxy-
genation, as detailed (40, 50, 51). Paired peripheral blood (PB) 
samples were collected in EDTA tubes on the occasion of rou-
tine venepuncture. PB from five age-matched control subjects 
(three females and two males) undergoing venepuncture for 
minor orthopedic procedures was used as a control. Cell-free 
SF and plasma were obtained by centrifugation of the specimens 
and stored at −80°C until assayed. SFMCs were isolated over a 
Ficoll cushion, as previously described (40, 50, 51). Informed 
written consent was obtained in accordance with the guidelines 
of the Gaslini’s Ethical Committee. Clinical and laboratory 
characteristics of patients at the time of sampling are reported 
in Table 1.
Flow cytometry
Flow cytometry was performed as described (40). Mf were 
resuspended with FACS buffer (PBS supplemented with 0.2% 
BSA, 0.01% NaN3) and stained with PE-conjugated mouse 
anti-human mAbs against CD14, CD80, CCR7, and TREM-1 
(clone 193015, obtained from BioLegend, Milano, Italy), CD68 
(obtained from Dako, Milano), CD206 (obtained from Miltenyi 
Biotec), CD86, HLA-DR, CD36 (BD-Pharmingen, Milano, Italy), 
and isotype-matched IgG (obtained from BioLegend) for 30 min 
at 4°C, after preincubation with rabbit IgG (obtained from Sigma) 
to block non-specific sites. Four-color flow cytometric analysis 
was carried out to analyze SFMCs using the following Abs: 
anti-CD68-FITC (obtained from Dako), anti-CD80-PE/Cy7, 
anti-CD206-APC, and anti-TREM-1-PE Abs (obtained from 
Biolegend). Fluorescence was quantitated on a FACSCalibur flow 
cytometer equipped with CellQuest software (BD-Biosciences). 
4Raggi et al. Functional Polarization of Human Mf
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Cells were gated according to their light-scatter properties to 
exclude cell debris.
Quantitative real-time rT-Pcr
Total RNA was purified from M1 and M2-polarized Mf using 
Trizol (Life Technologies, Monza, Italy) and controlled for integ-
rity with an Agilent Bioanalyzer 2100 (Agilent Technologies, 
Waldbroon, Germany). RNA was quantified by NanoDrop 
spectrophotometry (NanoDrop Technologies, Wilmington, 
NC, USA) and reverse-transcribed into cDNA on a GeneAmp 
PCR System 2700 thermal cycler (Applied Biosystems, Milano, 
Italy) using the SuperScript Double-Stranded cDNA synthesis 
kit (Life Technologies). qRT-PCR was performed on a 7500 
Real Time PCR System (Applied Biosystems) in triplicate for 
each target transcript using SYBRGreen PCR Master Mix (Life 
Technologies) and sense/antisense oligonucleotide primers 
synthesized by TIBMolbiol (Genova, Italy) or from Qiagen 
(Milano, Italy) (ribosomal protein S19, RSP19), as detailed (52). 
Expression data were normalized on the values obtained in par-
allel for three reference genes (actin-related protein 2/3 complex 
1B, ARPC1B; lysosomal-associated multispanning membrane 
protein-5, LAPTM5; RPS19), using the Bestkeeper software, and 
relative expression values were calculated using Q-gene software, 
as detailed (52).
elisa
Soluble (s)TREM-1 was quantified in cell-free Mf supernatants by 
human TREM-1 DuoSet (R&D Systems). Secreted IL-12, TNFα, 
IL-1β, CXCL8, IL-6, and IL-10 (Peprotech, Milano), osteopontin 
(OPN), CCL18, CCL24 and TGFβ1 (R&D Systems, Space Import 
Export, Milano, Italy) content in Mf CM was also measured by 
specific ELISA. HMGB1 levels were measured in SF and plasma 
from OJIA patients and age-matched controls using HMGB1 
ELISA kit II (IBL International, Hamburg, Germany); the lower 
limit of detection was 0.3 ng/mL. Optical density was determined 
using a Spectrafluor Plus plate reader from TECAN (Milano, 
Italy). All assays were done in duplicate.
TreM-1 crosslinking
Twelve-well flat-bottom culture plates were precoated with 10 µg/
mL of agonist anti-TREM-1 mAb (clone 193015, R&D Systems 
catalog no. MAB1278) or control IgG1 (R&D Systems) diluted 
in PBS overnight at 37°C. Eight ×105 M1 or M2-polarized Mf/
mL of fresh RPMI 1640 w/o cytokines were seeded in each well, 
briefly spun at 130 g to engage TREM-1, and then incubated for 
24 h under hypoxic conditions. Culture supernatants were then 
harvested by centrifugation and tested for cytokine/chemokine 
content by ELISA, and Mf were analyzed phenotypically.
ag Uptake assay
The 1 × 106 cells were incubated with FITC-labeled dextran beads 
(1 mg/mL; Sigma) in culture medium under normoxic or hypoxic 
conditions. After an incubation period of 30 or 60 min at 4°C and 
37°C, for background and active uptake values, respectively, cells 
were extensively washed with ice-cold PBS, and fluorescence was 
measured on a FACSCalibur.
statistical analysis
Statistical analyses were performed using the GraphPad Prism 
5 software (GraphPad Software, La Jolla, CA, USA). Data are 
expressed as the mean  ±  SEM of at least three independent 
experiments, unless differently specified. Statistical significance 
was evaluated by two-tailed paired Student’s t-test, unless differ-
ently specified. A p value <0.05(*), <0.01(**), or <0.001(***) was 
considered statistically significant.
resUlTs
lPs- and il-4-Treated human Mf exhibit 
surface Marker and secretory Profiles 
Typical of M1- and M2-Polarized subsets
M1 and M2 polarization states are defined by specific phenotypic 
and secretory patterns (17, 53, 54). Human Mf (M0) were gener-
ated by culturing primary Mn with the maturation factor, M-CSF, 
and then polarized toward the M1 and M2 activation states by 
stimulation with LPS and IL-4, respectively. Surface expression 
of the Mf differentiation marker, CD68, the prototypical M1 
marker, CD80, and the M2 marker, CD206, was then analyzed 
by flow cytometry to confirm polarization (Figures S1A,B in 
Supplementary Material). Panel A depicts the staining pattern of 
untreated, LPS, and IL-4-treated Mf from a representative donor 
and Panel B shows the percentage and mean fluorescence intensity 
(MFI) of CD80+ and CD206+ cells in LPS- and IL-4-polarized Mf 
from five different samples. CD68 was expressed at high levels on 
M0 cells, confirming Mf differentiation and maintained during 
polarization with both polarization stimuli. Low surface levels 
of the T cell costimulatory molecule, CD80, were detectable in 
unpolarized Mf, associated with high expression of the mannose 
receptor, CD206 in about 30% of cells. LPS-treated Mf exhibited 
the typical M1 phenotype, characterized by strong induction of 
CD80 and downregulation of CD206 compared to unpolarized Mf 
both in terms of percentage of positive cells and MFI. Conversely, 
IL-4-treated cells displayed phenotypic features of M2-polarized 
cells, such as high surface expression of CD206, that was upregu-
lated respect to unstimulated Mf, and low levels of CD80. CD80 
and CD206 expression were significantly (p < 0.001) decreased 
and increased, respectively, in IL-4- compared to LPS-treated Mf 
both in terms of percentage of positive cells and MFI.
The content of cytokines/chemokines associated with M1 or 
M2 activation states was then measured in Mf supernatants by 
ELISA, using M0 cells as a control (Figure S1C in Supplementary 
Material). LPS-treated cells released significantly higher levels of 
the M1-type cytokines, TNFα (p < 0.001), IL-12 (p < 0.05), and 
IL-1β (p < 0.05) compared to both untreated and IL-4-treated 
Mf, which failed to release detectable levels of IL-1β and secreted 
little or negligible amounts of IL-12 and TNFα. In contrast, 
unstimulated and IL-4-treated Mf released similar high amounts 
of the M2 cytokines/chemokines, TGFβ and CCL24, that were 
significantly decreased (p < 0.05) by LPS stimulation, whereas 
CCL18 secretion was significantly increased (p < 0.001) in LPS-
treated as compared to untreated Mf and further upregulated 
(p  <  0.001) upon stimulation with IL-4, in agreement with 
previous findings (13).
FigUre 1 | Effects of hypoxia on M1 and M2 polarization markers. M1- and M2-polarized Mf were generated from M-CSF-treated primary Mn stimulated with LPS 
and IL-4, respectively, under normoxic or hypoxic condition. (a,B) Surface marker expression. CD80 and CD206 surface levels were compared by flow cytometry. 
Histograms depict the results obtained in one representative donor; the blue lines represent the fluorescent profile of normoxic cells, and the red lines represent the 
fluorescent profile of hypoxic cells stained with the indicated Abs; the percentage of positive cells is indicated. The scatter plots represent the percentage of positive 
cells from five different donors (dots) with horizontal lines indicating mean values for each group. The bar graphs represent the means of mean fluorescence intensity 
(MFI) ± SEM of positive cells in five different donors. p values of M1 relative to H-M1, M2 relative to H-M2: *p < 0.05; **p < 0.01; ***p < 0.001. (c) Cytokine/
chemokine secretion. The concentration of the indicated cytokines/chemokines was measured by specific ELISA in the supernatants from normoxic (open bars) and 
hypoxic (full bars) M1 and M2 cells. Results are expressed as pg/8 × 105 cells/mL and represent the mean ± SEM of five different experiments. p values of M1 
relative to M2, M1 relative to H-M1, M2 relative to H-M2, H-M1 relative to H-M2: *p < 0.05; **p < 0.01; ***p < 0.001.
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Collectively, these data confirm M1 and M2 polarization state 
of LPS- and IL-4-treated Mf.
The hypoxic environment exerts  
M2-Polarizing effects on Mf
To determine the impact of hypoxia on Mf polarization, surface 
marker expression and cytokine release were compared in M1- 
and M2-polarized Mf generated under normoxic (20% O2) and 
hypoxic (1% O2) (hereafter referred to as H-M1, and H-M2) 
conditions (Figure  1). The effect of the hypoxic environment 
on control Mf (hereafter referred to as H-M0) was assessed in 
parallel (Figure S2 in Supplementary Material). As determined by 
flow cytometry, Mf generated under hypoxia exhibited different 
patterns of surface marker expression compared to their nor-
moxic counterparts. Hypoxia led to a significant increase in the 
percentage (p < 0.01) and MFI (p < 0.05) of CD206+ H-M0 cells, 
that reached levels comparable to those shown by M2-polarized 
cells, without substantially affecting CD80 expression (Figure 
S2A in Supplementary Material). A significant upregulation of 
CD206 expression was also observed in H-M1 compared to M1 
both in terms of percentage of positive cells (p < 0.01) and MFI 
(p < 0.001), that reached levels close to those observed in H-M0 
cells and was associated with a significant reduction (p < 0.001) 
in the fraction of CD80+ cells and the level of expression of the 
molecule (Figure 1A). Similar to H-M1, H-M2 exhibited signifi-
cantly decreased (p < 0.01) expression of CD80, both in terms 
of percentage of positive cells and MFI, and increased CD206 
surface levels (MFI, p < 0.05) respect to M2 cells, although with 
some variability among individual donors (Figure 1B).
Consistent with phenotypic data, we found profound dif-
ferences in cytokine/chemokine release between hypoxic and 
normoxic Mf under both M1- and M2-polarizing conditions 
(Figure 1C). With regard to the M1-type cytokines, a 70% reduc-
tion in the mean amounts of secreted TNFα was measured in 
the supernatants of H-M1 relative to M1 cells from 5 different 
donors (from 9,817 ± 803 to 2,897 ± 139 pg/mL; p < 0.001), and 
IL-12 secretion was almost completely inhibited (from 204 ± 53 
to 8.8 ± 8.8 pg/mL). Conversely, IL-1β secretion was increased by 
≈18-fold (from 83 ± 27 to 1,497 ± 295 pg/mL; p < 0.01) under 
hypoxia. Release of M2-type cytokines was also differentially 
modulated following M1 polarization under hypoxia. An increase 
6Raggi et al. Functional Polarization of Human Mf
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of ≈2.8-fold in the amounts of secreted TGFβ (from 314 ± 7 to 
877 ± 332 pg/mL) was measured reaching levels higher, although 
not significantly, than those released by M2 cells, whereas 
secreted CCL18 levels were reduced by about 72% (from 761 ± 87 
to 210 ±  45 pg/mL; p <  0.01) and CCL24 production was not 
affected (from 500 ± 113 to 548 ± 165 pg/mL). In M2-polarized 
Mf, hypoxia was effective at inhibiting TNFα (from 45 ± 45 to 
27 ± 19 pg/mL), CCL18 (from 1,851 ± 174 to 1,515 ± 179 pg/
mL), and CCL24 (from 718 ± 138 to 443 ± 119 pg/mL) release (by 
a mean of about 50, 20, and 40%, respectively), even if differences 
did not reach statistical significance given the high variability 
among different samples, while it did not affect secretion of IL-12 
(from 2.4 ± 2.4 to 3.2 ± 3.2 pg/mL), IL-1β (0.0 ± 0.0 pg/mL), and 
TGFβ (from 493 ± 97 to 456 ± 92 pg/mL). Secretory changes were 
also induced upon M0 differentiation under hypoxic conditions. 
Hypoxia significantly (p < 0.05) inhibited IL-12 (from 32 ± 9 to 
8 ± 7 pg/mL), CCL18 (from 109 ± 28 to 39 ± 21), and CCL24 
(from 695 ± 74 to 396 ± 63) secretion (by a mean of about 75, 
64, and 43%, respectively) in three different donors, whereas it 
increased by about 1.5-fold TGFβ release (from 407 ±  149 to 
610 ±  185) (Figure S2B in Supplementary Material), without 
affecting IL-1β and TNFα (data not shown).
We conclude that the hypoxic environment hinders Mf polari-
zation toward the classically activated phenotype and promotes 
the acquisition of some phenotypic and secretory features typical 
of alternative activation.
hypoxia Triggers several Phenotypic, 
secretory, and Functional changes  
in Polarized Mf
To better characterize the effects of hypoxia on Mf polarization, we 
investigated the relative expression of surface molecules involved 
in migration, T cell activation, Ag presentation, and scavenging in 
Mf polarized under normoxic and hypoxic conditions (Figure 2), 
compared to control M0 (Figure S2A in Supplementary Material). 
In line with previous observations (22, 49, 53, 54), elevated 
membrane levels of the CD86 costimulatory receptor, the MHC 
class II molecule, HLA-DR, and the scavenger receptor, CD36, 
were constitutively expressed on Mf, although expression tended 
to be higher in M2- and lower in M1-polarized Mf as compared 
to the unpolarized counterpart. Conversely, the percentage of Mf 
expressing the homing chemokine receptor, CCR7, was increased 
by M1-polarization and decreased by M2-polarization, confirm-
ing earlier reports (19, 54). Interestingly, hypoxia significantly 
decreased (p <  0.05) the percentage of CD86+ and HLA-DR+ 
cells and/or their expression levels in both M1 and M2 polarized 
Mf compared to their normoxic counterpart and almost com-
pletely inhibited CCR7 expression, while significantly enhancing 
the percentage of CD36 positive cells and their MFI (p <  0.01 
in H-M1, p <  0.05 in H-M2) as well as CD68 MFI (p <  0.05) 
(Figure 2). Significant downregulation of CCR7 and upregulation 
of CD36 in response to hypoxia were also observed in uncommit-
ted Mf (cell percentage, p < 0.01; MFI, p < 0.05) (Figure S2A in 
Supplementary Material).
We then investigated the release of a set of cytokines/
chemokines known to be modulated by hypoxia (55). As depicted 
in Figure  3A and Figure S2B in Supplementary Material, 
M1-polarized Mf secreted significantly higher levels of IL-6 
(735.6 ±  62  pg/mL; p <  0.001), CXCL8 (51.8 ±  15.7  ng/mL; 
p < 0.05), and IL-10 (24,162 ± 2,301 pg/mL; p < 0.001) compared 
to both M2 (IL-6, 5.8 ±  1.5  pg/mL; CXCL8, 2.3 ±  1.2  ng/mL; 
IL-10, 48 ±  22.1  pg/mL) and unpolarized (IL-6, 8 ±  4  pg/mL; 
CXCL8, 0.365 ± 0.07 ng/mL; IL-10, 9.7 ± 2 pg/mL) Mf, whereas 
all Mf subsets secreted comparable high amounts of osteopontin 
(OPN) (M0, 1,057 ±  252  ng/mL; M1, 707 ±  181  ng/mL; M2, 
607 ± 134 ng/mL). Secretion of CXCL8 and OPN was increased 
by about 3- and 1.7-folds (156.8 ±  32.9 vs. 3.85 ±  1  ng/mL; 
p < 0.05) and 2.5- and 3.4-fold (1,746 ± 361 vs. 2,060 ± 393 ng/
mL; p < 0.05) in H-M1- and H-M2-cells, respectively, compared 
to their normoxic counterparts (Figure 3A). OPN secretion lev-
els were also increased although not significantly (1,500 ± 32 ng/
mL) in the supernatants of H-M0 compared to M0 cells, whereas 
CXCL8 release was downregulated by about 70% (111 ± 19 pg/
mL, p <  0.05) (Figure S2B in Supplementary Material). A 20 
and 80% reduction in the amounts of secreted IL-6 (606 ± 23.7 
vs. 735  ±  62  pg/mL; p  <  0.05) and IL-10 (4,940  ±  934 vs. 
24,162 ±  2,301  pg/mL; p <  0.001), respectively, was measured 
in the supernatants of H-M1 relative to M1 cells (Figure  3A). 
Inhibition of IL6 (by 84%; 1.3 ± 1.3 pg/mL) and IL-10 (by 60%; 
4 ±  2.3  pg/mL, p <  0.01) release was also observed in H-M0 
respect to M0 cells (Figure S2B in Supplementary Material), 
whereas no differences in their secretion were observed between 
H-M2 and M2 cells (Figure 3A).
Macrophages are important endocytic cells, and polariza-
tion is associated with changes in endocytic activity (3, 17). 
Experiments were thus carried out to investigate whether 
hypoxia affected endocytic activity of M1- and/or M2-polarized 
cells, by assessing their ability to take up FITC-labeled dextran. 
At 4°C, both M1 and M2 cells were unable to capture Ag because 
of inhibition of cell metabolism, whereas at 37°C, dextran uptake 
was significant after 30 min and progressively increased until 1 h 
in both cell subsets (data not shown). As depicted in Figure 3B, 
M2 cells displayed significantly higher (p  <  0.0.05) dextran 
uptake than M1 cells, in line with previous evidence (13, 22). 
Differentiation under hypoxia caused a 40% decrease in dextran 
uptake by M2 cells, whereas it only slightly decreased that by 
M1 cells.
Overall, these data demonstrate that the response pattern of 
both M1- and M2-polarized Mf is markedly modulated upon 
generation in a hypoxic environment, resulting in decreased 
expression of molecules involved in migration, T cell activation, 
Ag presentation, associated with impaired Ag uptake activity, and 
in enhanced scavenging receptor expression and proangiogenic 
cytokines/chemokines production.
hypoxia is an inducer of TreM-1 
expression in M1- and M2-Polarized Mf
Monocyte-lineage cell activation by hypoxia is associated with 
specific changes in the expression profile of a cluster of genes 
coding for immunoregulatory receptors (40, 41, 52). Among 
them, we have recently identified TREM-1 as a common hypoxia 
molecular target in both primary Mn and Mn-derived DCs and 
FigUre 2 | Differential regulation by hypoxia of phenotypic marker expression in M1/M2-polarized Mf. M1/M2 and H-M1/H-M2 cells were generated as described 
in the legend of Figure 1. Cells were stained with PE-conjugated Abs to CD86, CCR7, HLA-DR, CD36, and CD68 or isotype-matched controls and analyzed by 
flow cytometry. Results are expressed as detailed in the legend of Figures 1a,B. (a) Histograms depict the results obtained in one of three independent donors; 
positive cell percentage and mean fluorescence intensity (MFI) (between brackets) are indicated. (B) The scatter plots represent the percentage of positive cells from 
three different donors (dots) with horizontal lines indicating mean values for each group. The bar graphs represent the means of MFI ± SEM of positive cells in three 
different donors. p values of M1 relative to M2, M1 relative to H-M1, M2 relative to H-M2, H-M1 relative to H-M2: *p < 0.05; **p < 0.01.
7
Raggi et al. Functional Polarization of Human Mf
Frontiers in Immunology | www.frontiersin.org September 2017 | Volume 8 | Article 1097
Langerhans cells and an important regulator of their functions in 
a hypoxic environment (56). We were interested in investigating 
whether TREM-1 could affect the polarization of hypoxic Mf. 
Initial experiments were carried out to assess TREM-1 expres-
sion on polarized Mf. M0 Mf were tested in parallel experiments. 
As measured by flow cytometry, membrane-bound TREM-1 
was constitutively expressed at low levels on both unpolarized 
(Figure S2C in Supplementary Material, upper panels) and polar-
ized (Figure 4A) Mf, although M1 polarization induced higher 
expression, in line with previous results showing LPS stimulatory 
role on TREM-1 expression (38). A significant increase in the 
percentage of TREM-1+ cells and their MFI was observed in all 
subtypes upon differentiation under hypoxia, with the extent 
of induction higher in H-M1 and H-M2 (p < 0.01) (Figure 4) 
than in H-M0 (p < 0.05) (Figure S2C in Supplementary Material, 
upper panels). Accordingly, release of the soluble form of TREM-1 
(sTREM-1), derived from the shedding of membrane-bound 
TREM-1 (56, 57), was significantly increased in the supernatants 
of H-M1 and H-M2 (p < 0.01) (Figure 4B), and at a lower extent 
in those of M0 cells (p <  0.05) (Figure S2C in Supplementary 
Material, lower panel), compared to their normoxic counterparts 
(ranging from 150 ± 11 to 452 ± 66 pg/mL in M1, from 93 ± 31 
to 210 ± 43 in M2, and from 6 ± 3.7 to 47 ± 12 in M0 in different 
donors). Consistent with the protein expression data, marked 
upregulation of TREM-1 transcript levels were detected by qRT-
PCR in hypoxic relative to normoxic polarized cells (Figure 4C), 
with the extent of increase ranging from 10- to 25-fold and 
from 4- to 10-fold in H-M1 and H-M2 from five tested donors, 
respectively.
These findings demonstrate that hypoxia is a critical determi-
nant of TREM-1 expression in Mf and that its stimulatory effects 
are enhanced following polarization.
FigUre 3 | Modulation by hypoxia of cytokine/chemokine secretion and endocytic activity in M1/M2-polarized Mf. M1/M2 and H-M1/H-M2 cells were generated  
as described in the legend of Figure 2. (a) Cytokine/chemokine secretion. Cell-free supernatants were harvested from M1/M2 (open bars) and H-M1/H-M2  
(full bars) cultures and assayed for the indicated cytokine/chemokine content by ELISA. Results are expressed as pg/8 × 105 cells/mL (IL-6, CXCL8, IL-10) or 
ng/8 × 105 cells/mL (OPN) and represent the mean ± SEM of five different experiments p value: *p ≤ 0.05; **p ≤ 0.01; ***p < 0.001. (B) Endocytic activity. M1/M2 
and H-M1/H-M2 cells were incubated for 60 min with FITC-dextran at 4 and 37°C under normoxic and hypoxic conditions, and dextran uptake was determined by 
flow cytometry. Results are expressed as geometric mean fluorescence intensity (MFI) of cells taking up dextran at 37°C subtracted from that of cells incubated at 
4°C (ΔGeoMean). The mean ± SEM of three independent experiments is shown. p values of M1 relative to M2 and H-M1 relative to H-M2: *p ≤ 0.05.
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TreM-1 engagement on hypoxic Mf 
imparts a Proinflammatory M1-skewed 
Phenotype to Mf
Crosslinking experiments were then carried out to investigate the 
impact of TREM-1 activation on Mf polarization under hypoxia. 
To this aim, H-M1 and H-M2 cells were cultured for additional 
24  h in plates pre-coated with a specific anti-TREM-1 agonist 
mAb and then phenotypically and functionally characterized. As 
determined by flow cytometry (Figure 5), the percentage of cells 
expressing CD80 (p < 0.01), CD86 (p < 0.05), CCR7 (p < 0.05), 
and HLA-DR (p < 0.05) was significantly increased in response 
to TREM-1 triggering, as compared to cells crosslinked with an 
irrelevant isotype-matched control mAb, whereas surface levels 
of CD206 were significantly (p < 0.01) downregulated, in both 
subsets.
Supernatants from TREM-1-triggered H-M1 and H-M2 
cells were collected and analyzed for cytokine and chemokine 
content by ELISA. As depicted in Figure 6A, TREM-1 engage-
ment resulted in a significant and consistent increase in the 
secreted amounts of the M1 cytokines, TNFα and IL-1β, and in 
de novo release of low levels of IL-12 by both subsets. Among 
M2 cytokines, TREM-1-triggered H-M1- and H-M2 produced 
increase amounts of CCL24, whereas no effect was observed on 
FigUre 4 | TREM-1 upregulation in H-M1- and H-M2-polarized Mf. M1/M2 and H-M1/H-M2 cells were generated as described in the legend of Figure 2.  
(a) TREM-1 surface expression. Cells were stained with PE-conjugated TREM-1 Ab, and TREM-1 membrane expression was assessed by flow cytometry. Results 
are expressed as in the legend of Figure 2. Histograms depict the results obtained from one representative experiments of five performed; positive cell percentage 
and mean fluorescence intensity (MFI) (between brackets) are indicated. Scatter plots represent the percentage of TREM-1-expressing cells from five different 
donors (dots), with horizontal line representing mean values for each group. The bar graphs represent the MFI ± SEM of TREM-1+ cells in five different donors.  
p values of M1 relative to H-M1, M2 relative to H-M2: **p < 0.01; ***p < 0.001. (B) sTREM-1 secretion. sTREM-1 concentration in cell-free supernatants was 
measured by ELISA in the same preparations analyzed in panel A. Results are shown as a box plot and expressed as pg/8 × 105 cells/mL. Boxes contain the values 
falling between the 25th and 75th percentiles, horizontal lines represent mean values, and whiskers (lines that extend from the boxes) represent the highest and 
lowest values for each group. p values of M1 relative to H-M1 and M2 relative to H-M2: **p < 0.01. (c) TREM-1 mRNA expression. TREM-1 transcript levels were 
quantified by qRT-PCR in total RNA. Data are expressed as mean normalized expression, calculated on the basis of triplicate measurements for each experiment/
donor, relative to the values obtained in parallel for three reference genes. Results from a representative of five tested donors are shown. Fold increase values in 
hypoxic versus normoxic (considered as equal to 1) cells are indicated by a number associated with each bar.
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the production of TGFβ and CCL18 regardless of Mf polarizing 
conditions. TREM-1 crosslinking also led to increased secretion 
of IL-6, CXCL8, OPN, and IL-10 by both H-M1 and H-M2 cells, 
as compared to the IgG-triggered counterparts. Interestingly, the 
stimulatory effect of TREM-1 on all tested cytokines/chemokines, 
with the exception of OPN, was higher in H-M2- than H-M1-
polarized Mf, indicating that the extent of Mf responsiveness 
to TREM-1 activation depends on the type of pre-stimulation. 
No substantial differences in marker expression and cytokine 
secretion were observed upon macrophage crosslinking with an 
isotype-matched anti-HLA-1 mAb as compared to control IgG, 
confirming that Mf activation by anti-TREM-1 was specific and 
not the result of Fc receptor ligation (data not shown).
We then investigated whether Mf endocytic ability was 
modulated upon TREM-1 triggering by comparing the ability of 
TREM-1- and control IgG-triggered H-M1 and H-M2 cells to 
FigUre 5 | Modulation of H-M1 and H-M2 cell phenotype by TREM-1-cross-linking. H-M1 and H-M2 cells generated as described in the legend of Figure 2 were 
seeded onto plates pre-coated with agonist anti-TREM-1 mAb or control IgG and cultured for additional 24 h under hypoxic conditions. Cells were then harvested, 
and surface expression of the indicated markers was determined by flow cytometry. (a) Histograms depict the results obtained from a representative of three tested 
donors. The blue and the red lines represent, respectively, the fluorescent profile of IgG- and TREM-1-triggered cells stained with the indicated Abs; positive cell 
percentages are indicated. (B) The scatter plots represent the percentage of positive cells from three different donors (dots) with horizontal lines indicating mean 
values for each group. The bar graphs represent the means of MFI ± SEM of positive cells in three different donors. p value of TREM-1- relative to IgG-triggered 
H-M1/H-M2 cells: *p ≤ 0.05; **p ≤ 0.01.
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take up dextran. As shown in Figure 6B, both H-M1 and H-M2 
cells responded to TREM-1 activation by a twofold increase of 
dextran uptake, which reached levels higher than those observed 
in the normoxic counterparts.
Overall, these data suggest that TREM-1 triggering reverses 
the M2-polarizing effect of hypoxia imparting a M1-skewed 
proinflammatory phenotype to Mf.
Mf infiltrating the hypoxic sF of OJia 
Patients express TreM-1 and are 
Polarized toward a M1 Phenotype
Triggering receptor expressed on myeloid cell 1 has been impli-
cated in the pathogenesis of several infectious and non-infectious 
chronic inflammatory disorders, including rheumatic diseases 
(58–61), which are characterized by hypoxia and high Mn cell 
infiltration (5). Experiments were carried out to assess expression 
of TREM-1 and Mf phenotype in the SF of patients affected by the 
pediatric chronic rheumatic condition, OJIA (OJIA-SF). To this 
aim, SFMCs were isolated from the active knee joints of six OJIA 
patients and subjected to four-color flow cytometric analysis with 
mAbs to CD68, CD80, CD206, and TREM-1 (Figure 7). A large 
subset of SFMCs expressed CD68, confirming Mf enrichment 
in OJIA-SF. An elevated percentage of CD68+ cells, representing 
≈60% of the total CD68-gated population in the six patients 
analyzed, expressed the CD80 marker (Figure  7A, upper left 
quadrants; Figure  7B), whereas only the 2.5% of CD68+ cells 
expressed the CD206 marker (Figure 7A, lower right quadrants; 
Figure  7B), suggesting predominant polarization toward a M1 
proinflammatory phenotype. A subset of CD68+ cells, that repre-
sented ≈12% of the total CD68-gated cells exhibited a mixed M1/
M2-type phenotype coexpressing the CD80 and CD206 markers 
FigUre 6 | Modulation of H-M1 and H-M2 secretory features and endocytic activity by TREM-1-cross-linking. H-M1 and H-M2 cells were crosslinked with the 
anti-TREM-1 Ab as described in the legend of Figure 5. (a) Cytokine/chemokine secretion. Supernatants were assayed for the indicated cytokines/chemokines 
content by specific ELISA. Data shown are expressed as fold changes in TREM-1- relative to IgG-crosslinked cells (arbitrarily defined as equal to 1) and represent 
the mean of five independent experiments. (B) Endocytic activity. Ig- and TREM-1-triggered H-M1/H-M2 cells were incubated with FITC-dextran at 4 and 37°C for 
1 h under normoxic and hypoxic conditions, respectively, and then analyzed by flow cytometry. Results are expressed as detailed in the legend of Figure 4B and 
represent the mean ± SEM of three independent experiments. p value of TREM-1-triggered H-M2 relative to TREM-1-triggered H-M1 and IgG-triggered H-M2 
relative to IgG-triggered H-M1 cells: *p ≤ 0.05.
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(Figure  7A, upper right quadrants; Figure  7B). Interestingly, 
high TREM-1 expression was detected on the majority of CD80+ 
(about 92%) and CD206+ (about 81%) Mf (Figures 7A,B). These 
findings demonstrate that Mf generated from Mn recruited to the 
OJIA-SF express high levels of TREM-1 and are mostly polarized 
toward a M1 phenotype.
Given the predominant M1 polarization of TREM-1+ SF-Mf 
and the presence of a Mf subset with a mixed M1/M2 pheno-
type, probably representing M2-to-M1 switching cells, we asked 
whether SFs from OJIA patients could exert M2-to-M1 repolar-
izing effects via TREM-1 activation. To address this question, 
we evaluated the expression of CD80 and CD206 polarization 
markers on in vitro polarized H-M2 cells incubated for 24 h with 
OJIA-SFs in the presence or absence of the synthetic peptide, 
LP17, derived from a short highly conserved extracellular region 
of TREM-1 involved in ligand binding (44). As determined by 
flow cytometry (Figure 8), the percentage of H-M2 cells express-
ing CD80 was increased, whereas that of CD206 was decreased, 
following exposure to SFs as compared to the unexposed coun-
terparts, although variability in the response to different SFs was 
observed, and LP17 addition to the culture partially attenuated 
these effects. The control peptide displayed no activity on pheno-
typic marker expression (not depicted). These data suggest that 
OJIA-SF can promote some M2-to-M1 repolarization and that 
this response is mediated at least in part by TREM-1 activation, 
raising the possibility that putative TREM-1 ligands may be 
present in OJIA SF.
Previous reports have suggested a role for TREM-1 in the 
recognition of DAMPs (45, 56), endogenous molecules released 
by activated inflammatory and/or damaged/necrotic cells and 
implicated to the initiation and perpetuation of the inflammatory 
process in various inflammatory arthritic diseases (62). In par-
ticular, the nuclear DNA-binding protein, HMGB1, has been 
recently identified as a natural ligand of TREM-1 in mice (46). 
We were, thus, interested in investigating whether HMGB1 was 
present in the SF from OJIA patients. HMGB1 concentrations 
were measured by ELISA in paired SF and plasma samples from 
OJIA patients and in plasma from five age-matched control 
subjects, used as control. As shown in Figure 9, elevated levels 
of HMGB1 were detectable in SF from OJIA patients (median 
57.3 ± 9.5, range 35–89 ng/mL), that were significantly increased 
as compared to those present in paired (median 3.1 ±  0.3  ng/
mL, p < 0.01) and control (median 3.5 ± 0.45 ng/mL, p < 0.001) 
plasma samples. These results suggest that release of the putative 
TREM-1 ligand, HMGB1, is induced in the inflamed arthritic 
environment.
DiscUssiOn
Macrophages can be polarized into specialized functional subsets 
both under physiological (e.g., embryogenesis and pregnancy) 
and pathological conditions (e.g., cancer, autoimmune disease, 
chronic inflammation, infection, and tissue repair) (3, 8). Recent 
studies have highlighted the complexity of in vivo Mf polarization, 
which goes beyond the simple M1–M2 paradigm and represents a 
continuum of diverse functional states with intermediate or over-
lapping features (9, 12, 17, 30). Coexistence of cells in different 
polarization states and unique or mixed M1/M2 phenotypes have 
been observed in selected preclinical and clinical conditions, and 
Mf polarization status was shown to change over time throughout 
the course of the disease (8, 22, 23). Tissue environment has been 
implicated as the strongest factor in the determination of Mf 
FigUre 7 | Triggering receptor expressed on myeloid cell (TREM)-1 expression in vivo in Mf from hypoxic oligoarticular juvenile idiopatic arthritis synovial fluid 
(OJIA-SF). SF mononuclear cells (SFMCs) were purified from children affected by OJIA, stained with anti-CD68-FITC, anti-CD80-PE/Cy7, anti-CD206-APC, and 
anti-TREM-1-PE mAbs, and analyzed by multicolor flow cytometry on a FACScan. (a) Results from two representative of six OJIA patients are shown as flow 
cytometry plots. Myeloid cell populations were electronically gated according to their forward/side scatter properties. Gated cells were analyzed for CD68 positivity, 
and CD68+ cells were then examined for CD80 and CD206 expression. Non-specific staining was corrected using isotype-matched Abs. The percentage of single 
and double-positive cells within the CD68-gated population is indicated. Upper left quadrants: CD80+/CD206 cells (M1 phenotype); lower right quadrants: 
CD80CD206+ cells (M2 phenotype). Upper right quadrants: CD80+/CD206+ cells (mixed M1/M2 phenotype); lower left quadrants: control IgGs. Coexpression of 
TREM-1 in CD80+ and CD206+ cells was then evaluated. Red histograms represent the fluorescent profile of TREM-1-expressing cells, whereas blue histograms 
represent the fluorescent profile of cells stained with the isotype-matched control Ab. The percentage of TREM-1+ cells in the total CD80+ and CD206+ populations 
is indicated (B) Percentages of CD80 and CD206 single and double-positive cells within the CD68-gated population and percentages of TREM-1+ cells in the total 
CD80+ and CD206+ subsets are presented as bar graphs. Results are the mean ± SEM of six independent experiments. *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001.
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activation profile (6). In this study, we present novel data demon-
strating that a chronic hypoxic environment reflecting that occur-
ring in vivo in diseased tissues critically impacts on the polarization 
of human Mf, counteracting the effects of classically activating 
stimuli while promoting the acquisition of some phenotypic and 
secretory features typical of alternative activation. Furthermore, 
we provide the first evidence of the role of the TREM-1 receptor 
in reversing the M2 polarizing effects of hypoxia, driving hypoxic 
Mf reprogramming toward a M1 proinflammatory direction, with 
implications for OJIA pathogenesis.
Clear differences in the morphology, phenotype, secreted 
cytokine pattern, transcriptional profile, and endocytic activity 
between M1- and M2-polarized Mf have been reported (34, 49, 
53, 54, 63). In agreement with data in the literature, LPS- and 
IL-4-stimulated human Mf displayed the M1 (CD68+/CD80high/
CD206/low) and the M2 (CD68+/CD80/low/CD206high), phenotype, 
respectively, as compared to unstimulated Mf that displayed the 
M0 phenotype (CD68+/CD80/low/CD206low). Increased surface 
expression of CCR7, previously associated with M1 polarization 
(19, 49, 54), was detectable in LPS- respect to IL-4-treated Mf, 
FigUre 9 | High-mobility group box 1 (HMGB1) release in synovial fluid (SF) 
and plasma from patients affected by oligoarticular juvenile idiopatic arthritis 
(OJIA). HMGB1 concentrations were quantified by ELISA in paired plasma 
and SF from the OJIA patients analyzed in Figure 7 and in plasma from five 
age-matched control subjects. Individual samples were run in duplicate. 
Results are expressed as ng/mL Boxes show the values falling between the 
25th and 75th percentiles, horizontal lines represent mean values, and 
whiskers the highest and lowest values for each group. p value of SF relative 
to paired OJIA plasma (by two-tailed paired Student’s t-test): **p < 0.01;  
p value of SF relative to plasma controls (by two-tailed unpaired Student’s 
t-test): ***p < 0.001.
FigUre 8 | Modulation of CD80 and CD206 polarization markers by oligoarticular juvenile idiopatic arthritis synovial fluid (OJIA-SF) and LP17 peptide in H-M2 cells. 
H-M2 cells generated from two different donors were cultured for 24 h under hypoxic conditions with SFs from the OJIA patients analyzed in Figure 7 (three SFs for 
each H-M2 preparation) in the presence or absence of the TREM-1-specific peptide, LP17 (100 ng/mL). Surface levels of CD80 and CD206 were then determined 
by flow cytometry. Results are expressed as in the legend of Figure 2B. Scatter plots represent the percentage of positive H-M2 cells untreated or treated with three 
different SF ± LP17 (dots), with horizontal lines indicating mean values for each group. p value of SF + LP17- relative to SF-treated cells (by two-tailed paired 
Student’s t-test): *p ≤ 0.05.
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which conversely expressed higher amounts of the M2 marker, 
CD36, and of the CD86 and HLA-DR molecules. CD86 and 
MHC-class II molecules were reported to be only minimally 
expressed in IL-4-polarized Mf in mice (10), reinforcing the 
notion that mouse and human Mf differ in the expression levels 
of some M1–M2 polarization markers (12, 13, 19, 34, 35, 37, 54). 
Given their role in the balance between Th1 and Th2 development 
through CD28 engagement on T cells (64), the observation that 
CD80 and CD86 expression levels are higher in human M1- and 
M2-polarized Mf, respectively, confirms the respective Th1- and 
Th2-supporting properties of the two subsets (9, 10). Phenotypic 
M1 and M2 polarization was paralleled by secretion of a distinct 
set of cytokines/chemokines, with high amounts of the proinflam-
matory Th1-priming cytokines, IL-12, TNFα, IL-1β, and IL-6 
released by LPS-treated Mf but not by IL-4-treated Mf, that in 
contrast exhibited increased production of the immunosuppres-
sive cytokine, TGFβ, and the chemokines, CCL18 and CCL24, in 
agreement with earlier reports (17, 19, 54). Interestingly, higher 
levels of the anti-inflammatory cytokine, IL-10, were released by 
M1 than M2-polarized Mf. IL-10 has long been considered as a 
M2 marker based on studies in mice (9, 10, 17). Conversely our 
data demonstrate that human M1-polarized Mf are important 
IL-10 producers, corroborating recent findings (13, 54, 63) and 
highlighting relevant interspecies variability also with regard to 
M1–M2 secreted cytokines. The observation that uncommitted 
M0 Mf produced little or negligible TNFα, IL-1β, IL-6, and IL-10 
as well as increased TGFβ and CCL24 and expressed higher CD206 
and CD36 than LPS-treated Mf without reaching the levels shown 
in IL-4-polarized cells suggest that M-CSF-driven Mf maturation 
induces a moderate M2-oriented activation state. However, the 
presence of some M1-like features, such as expression of CCR7 
and production of IL-12, indicate the lack of complete M2 polari-
zation, that was induced upon treatment with IL-4 and reversed 
by LPS, supporting previous findings by others (13, 14, 19, 49, 
53, 54). In addition to differences in surface marker expression 
and cytokine production, M1-and M2-polarized Mf differed with 
regard to endocytic capacity, as shown by a significantly higher 
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(p <  0.0.05) dextran uptake by IL-4- compared to LPS-treated 
cells, in agreement with previous reports (20, 22).
Macrophages response to M1- and M2-polarizing stimuli was 
markedly modulated upon generation under a hypoxic environ-
ment. LPS-treated hypoxic Mf exhibited significantly lower 
surface levels of the M1 markers, CD80 and CCR7, and con-
comitant significant increase in the expression of the M2 markers, 
CD206 and CD36, compared to their normoxic counterparts, 
thus displaying a phenotype similar to that of IL-4-treated Mf. 
Accordingly, cytokines/chemokines produced by hypoxic LPS-
polarized Mf switched from the M1- to the M2-type. Secretion of 
IL-12, TNFα, IL-6, and IL-10 was, in fact, significantly reduced 
whereas that of TGFβ and the proangiogenic mediators, CXCL8 
and OPN, was increased under hypoxia, although statistically 
significant differences were evident only for CXCL8 and OPN. 
Similarly to LPS-polarized Mf, unpolarized and IL-4-polarized 
hypoxic Mf exhibited significant upregulation of CD206 and 
CD36 associated with significant downregulation of CCR7, as 
well as increased production of OPN, compared to cells differ-
entiated under normoxia, confirming the M2-polarizing effects 
of hypoxia. Significant downregulation of CD80 and increase of 
CXCL8 were also observed in IL-4-polarized hypoxic Mf, whereas 
decreased secretion of IL-12, IL-6, and IL-10 and increased release 
of TGFβ were induced by hypoxia in M0. These results point to 
a role of the hypoxic environment as a direct trigger of human 
Mf polarization toward the M2 activation state, reinforcing the 
effects of M2-polarizing stimuli and re-educating M1-polarized 
macrophages toward alternative activation by counteracting the 
effects of classical activation stimuli. These findings confirm and 
extend recent reports in TAMs (31, 32, 65, 66), although divergent 
results have also been obtained (33). Reversal of Mf proinflam-
matory responses to LPS was previously shown to occur upon 
stimulation with immunocomplexes (10, 16), and we extend this 
observation to hypoxia, suggesting that LPS can differently affect 
Mf functions depending on the type of pre- or costimulation. 
The observation that secretion of the M1 cytokine, IL-1β, was 
increased and that of the M2 chemokine, CCL18, was decreased 
in LPS-treated hypoxic Mf suggest their retainment of some 
properties typical of M1-polarized Mf, thus predicting a mixed 
M1/M2 polarization state upon development within pathologic 
hypoxic tissues. Indeed, a mixed M1/M2 phenotype was reported 
in TAM (8, 67) and adipose tissue Mf (22).
Impairment of Ag uptake ability is an important effect of 
hypoxia on Mn-derived immature DCs (iDCs) [for a review see 
Ref (55)]. Our data show that the hypoxic environment reduced 
the ability of M1 and M2-polarized Mf to take up dextran. Dextran 
endocytosis can occur via C-type lectin receptors, such as CD206, 
and we have previously reported the relation between dextran 
uptake inhibition in iDCs generated under hypoxia and CD206 
downregulation (68). Differently from DCs, inhibition of dextran 
uptake in Mf could not be ascribed to CD206, because it was 
upregulated by hypoxia, thus implicating other scavenger recep-
tors in mediating endocytic activity impairment in these cells. 
Downregulation of different surface endocytic scavenger recep-
tors involved in the uptake of lipids and lipoproteins, apoptotic 
cells, hemoglobin and glycoproteins in human Mn lineage cells in 
response to hypoxia has been previously reported (52). Inhibition 
of Ag uptake ability together with the observed decrease in the 
expression of HLA-DR, CD80, and CD86 molecules, which are 
involved in Ag presentation and T  cell costimulation, suggest 
that Mf generated at pathologic hypoxic sites are less efficient 
in triggering T cell responses compared to Mf generated under 
physiological conditions. Furthermore, the evidence that secre-
tion of IL-12, the main Th1-priming cytokine (69), and CCL18, a 
specific chemoattractant and activating cytokine for naive T cells 
and iDCs (70), was inhibited under hypoxia in M1-polarized Mf 
raises the possibility that their Th1-priming ability is impaired 
under hypoxic conditions, and further investigations are under-
way to address this hypothesis. Interestingly, these results confirm 
and extend our earlier evidence in Mn-derived Langerhans cell 
showing that hypoxia inhibits their expression of T cell costimu-
latory molecules and impairs their stimulatory activity on naive 
T cells (42), but differ from previous findings in Mn-derived DCs 
that demonstrated CD80 and CD86 molecule overexpression 
upon differentiation under conditions of reduced oxygenation 
(41, 68, 71). Taken together, these findings strongly suggest that 
hypoxia can differentially modulate the T cell stimulatory activity 
of distinct Mn lineage cell subsets.
Monocyte cell migratory activity is a tightly regulated process 
mediated by a specific repertoire of chemokine receptors and 
adhesion molecules, known to be highly sensitive to microen-
vironmental changes (7). Low pO2 was reported to significantly 
and differentially influence the chemokine receptor profile and 
the migratory behavior of cells belonging to the Mn lineage. 
We showed that hypoxia promoted the onset of a migratory 
phenotype in Mn-derived iDCs by inducing the expression of 
receptors for both inflammatory and homeostatic chemokines, 
such as CCR2, CCR3, CCR5, CXCR4, CX3CR1, with consequent 
increased responsiveness to specific chemoattractants (68, 71). In 
contrast, downregulation of CC inflammatory chemokine recep-
tors, namely CCR5, CCR2, and CCR1, was a common feature 
of primary Mn and Mn-derived Mf response to low pO2 and an 
important mechanism regulating their retainment/concentration 
in hypoxic areas of inflammatory and tumor lesions (7, 52, 72). 
The demonstration that hypoxia inhibits CCR7 expression on 
unpolarized Mf a well as under both M1- and M2-polarization 
conditions is compatible with the hypothesis that reduced tissue 
oxygenation impairs Mf trafficking in vivo.
Myeloid cells integrate signals present in the microenviron-
ment through a defined repertoire of activating and inhibitory 
surface immunoregulatory receptors, which play a major role in 
the regulation of their responses in diseased tissues (56, 73). We 
demonstrated by gene expression profiling the fine regulatory 
control exerted by hypoxia on the expression of various mem-
bers of these receptor family in primary Mn and Mn-derived 
DCs (40,  41, 52, 55). Elucidation of hypoxia effects on immu-
noregulatory receptor expression and functions in Mf may help 
to unravel the mechanisms underlying their polarization at 
pathologic sites and result in the identification of novel ways of 
therapeutic manipulation. An intriguing finding of this study is 
the demonstration that hypoxia strongly induces the expression 
of one of such receptors, TREM-1, in unpolarized Mf and that 
this effect is further enhanced in M1- and M2-polarized Mf. 
This molecule was previously reported to be developmentally 
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regulated in Mn-lineage cells, being constitutively expressed at 
high levels in primary Mn and completely downregulated during 
Mn differentiation into DCs and Langerhans cells (40, 41). Our 
results support these findings, showing low TREM-1 expression 
on M0-, M1-, and M2-polarized Mf generated under normoxia. 
Noteworthily, TREM-1 mRNA and membrane-bound receptor 
levels, as well as release of its soluble form detectable in several 
inflammatory disorders (56), were consistently and significantly 
increased upon Mf differentiation under chronic hypoxia. This 
evidence, together with previous observation showing TREM-1 
upregulation in primary Mn in response to hypoxia (52, 74) and 
inducibility in iDCs, mDCs, and Langerhans cells (40–42), is 
consistent with a role for hypoxia as a trigger of TREM-1 expres-
sion, indicating that hypoxic stimulation can overcome TREM-1 
developmental downregulation, and highlights the relevance of 
TREM-1 as a common marker of distinct Mn lineage cell popula-
tions in a hypoxic environment.
Triggering receptor expressed on myeloid cell 1 engagement 
on hypoxic Mf by an agonist mAb reverted the M2-polarizing 
effects of hypoxia imparting a proinflammatory M1-skewed phe-
notype to Mf. Features typical of M1 cells, namely expression of 
CD80 and CCR7 and secretion of IL-12, TNFα, IL-1β, and IL-6, 
were in fact stimulated upon TREM-1 crosslinking in hypoxic 
Mf irrespectively of their initially acquired polarization state and 
were paralleled by downregulation of the M2 marker, CD206. 
Upregulation of CD86 and HLA-DR expression and enhanced 
endocytic activity were also prominent features of TREM-1-
triggered hypoxic Mf, suggesting restoration of their T  cell 
stimulatory activity. These results provide the first evidence of 
TREM-1 ability to induce hypoxic macrophage reprogramming 
from the M2 to the M1 state, supporting and extending previous 
observations on macrophage dynamic shifting among functional 
phenotypes in  vitro upon sequential or concomitant treatment 
with different stimuli (6, 10, 15, 20, 21, 53). Increased secretion 
of classical M1-type proinflammatory cytokines together with 
that of CXCL8, a strong neutrophil chemoattractant (75), OPN, 
an important mediator of Mn cell and Th1 lymphocyte recruit-
ment (75, 76), and CCL24, a chemotactic factor for eosinophils, 
basophils, neutrophils, Th2 lymphocytes, and Mf (77), by TREM-
1-triggered hypoxic Mf strongly suggest that sustained TREM-1 
induction by the hypoxic environment represents an important 
mechanism of regulation of Mf-mediated inflammatory leukocyte 
recruitment/accumulation in pathologic tissues. Given CXCL8 
and OPN proangiogenic properties (75, 78), TREM-1 contribu-
tion to hypoxic Mf-mediated neovascolarization is also highly 
predictable. These findings corroborate and extend previous 
observations showing that TREM-1 engagement promotes the 
proinflammatory and Th1-priming functions of hypoxic DCs and 
Langerhans cells and their stimulatory activity on T cells (40, 41), 
emphasizing the relevance of this molecule in the activation of 
both innate and adaptive immunity at hypoxic sites.
Triggering receptor expressed on myeloid cell 1 has been 
implicated in the development and perpetuation of a number of 
non-infectious chronic inflammatory disorders (56), including 
adult arthritides (58–61). OJIA is the most common chronic pedi-
atric rheumatic disease, characterized by extensive and persistent 
inflammatory cell recruitment and retention in the synovium of 
affected joints, which are crucial to disease pathogenesis, and is 
an important cause of short- and long-term disability due to bone 
and cartilage destruction (5, 43). Hypoxia occurs in the inflamed 
rheumatic synovium in the course of the disease and was reported 
to play a pathogenetic role in OJIA by triggering further leukocyte 
infiltration and activation (5, 50, 51). We previously documented 
the presence of elevated amounts of sTREM-1 in the hypoxic 
synovial effusions of children affected by OJIA and identified 
TREM-1+ DCs as an important component of SF inflammatory 
infiltrate and a possible source of sTREM-1 (40, 41). Other 
groups also showed positivity for TREM-1 on myelomonocytic 
cells infiltrating synovial joints of rheumatoid arthritis patients 
(58–60). This study expands previous results providing the first 
evidence of high TREM-1 expression on CD68+ Mf enriched in 
OJIA-SF and demonstrating predominant polarization of TREM+ 
Mf toward the M1 phenotype, characterized by high CD80 and 
low CD206 expression. These findings support recent observation 
in obese patients showing positive correlation between TREM-1 
and M1 macrophage marker expression (79) and are consistent 
with the proinflammatory cytokine profile previously detected 
in the SF of JIA patients (5, 80, 81). Interestingly, we observed 
coexpression of CD80 and CD206 in a small fraction of Mf, in 
line with previous findings in circulating Mn from the systemic 
form of JIA (82), suggesting the presence of a subset of Mf with 
a mixed M1/M2 phenotype, probably representing M2-to-M1 
switching cells.
Taken together with in  vitro data, the observed correlation 
between TREM-1 expression and M1 polarization in OJIA-SF 
suggest that Mf generated from Mn recruited to the arthritic syn-
ovium respond to intra-articular hypoxia upregulating TREM-1, 
which may represent one of the mechanisms mediating their 
polarization to a M1 proinflammatory state. We hypothesize 
that, in the early phase of synovial inflammation, infiltrating Mn 
are induced by the local hypoxic environment to differentiate 
into M2-polarized Mf, which likely represents a mechanism to 
prevent immune cell overactivation and collateral inflammatory 
tissue damage (30). It is conceivable that at this stage TREM-1 
expression is induced on synovial Mf in response to intra-articular 
hypoxia but that its activation does not occur provided that rapid 
resolution of inflammation ensues. Conversely, if the inflamma-
tory process progresses, TREM-1 is activated by putative DAMP 
ligands (45, 56) released in the local arthritic environment as a 
result of chronic inflammation and/or cartilage/bone erosion (83), 
triggering M1 polarization of both M2-skewed hypoxic Mf and 
newly recruited Mn and unpolarized Mf, thus contributing to the 
amplification of OJIA synovitis. Consistent with this hypothesis is 
the observation that SFs from OJIA patients have M1 repolarizing 
activity on H-M2 cells in  vitro, although with a certain degree 
of variability probably due to their heterogeneity in immune cell 
composition and resultant soluble mediator content (5, 43), and 
that these effects are attenuated at least in part by treatment with 
the synthetic TREM-1-specific peptide, LP17, which was previ-
ously reported to function as an inhibitor of TREM-1 activation 
in vitro in human Mn and neutrophils (44, 84, 85) and in vivo 
in various preclinical models of microbial infections and non-
infectious inflammatory conditions [for a review see Ref (56).] 
by competing with the receptor for ligand binding. Furthermore, 
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the finding that high levels of the DAMP molecule, HMGB1 
(62), which was recently identified as a potential natural ligand 
of TREM-1 in mice (46), are present in the SF of OJIA patients 
[this study and Ref (86).], confirms the release of TREM-1 puta-
tive ligands in the inflamed arthritic environment, warranting 
future in-depth studies of TREM-1 activation in synovial Mf. 
Interestingly, the same proinflammatory cytokines released by 
TREM-1-triggered Mf or other inflammatory cells, e.g., TNFα, 
as well as bacterial products often present in the inflammatory 
milieu, can upregulate TREM-1 expression (87, 88), indicating 
the existence of both autocrine and paracrine positive feedback 
loops sustaining TREM-1 signaling. The extent of synovial Mf 
proinflammatory activation in affected joints will, thus, be 
ultimately dictated by the functional interplay among inflam-
matory mediators released both by macrophages in response to 
TREM-1 activation and other innate and adaptive immune cell 
populations recruited to the hypoxic synovium, which synergisti-
cally stimulate each other’s production (69), thereby generating 
a pathologic cycle of inflammation that leads to the chronicity 
of the disease. Hence, targeting TREM-1 may potentially have 
therapeutic benefits in OJIA by reducing synovial M1 polariza-
tion and local proinflammatory cytokine and chemokine release. 
TREM-1 blockade has previously been reported to be effective 
in  vivo in murine collagen-induced arthritis, an experimental 
mouse model of RA, attenuating inflammation and improving 
the clinical course of the disease (58). The therapeutic efficacy 
of inhibiting Mn lineage cell-derived proinflammatory cytokines 
has been previously reported in JIA (89).
In conclusion, results from this study highlight the fine 
regulatory control exerted by the pathologic hypoxic environ-
ment on Mf polarization, suggesting that Mf can blend into 
various “shades” of activation depending on the degree of local 
oxygenation, that is quite heterogeneous and rapidly fluctuating 
in diseased tissues (5, 24). Our results also suggest the potential 
of TREM-1 induction by intra-articular hypoxia on synovial Mf 
as a mechanism of amplification and perpetuation of the inflam-
matory process in OJIA with important therapeutic implications.
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